Skip to main content
Therma Bright Inc. logo

Therma Bright Inc. — Investor Relations & Filings

Ticker · THRM ISIN · CA8834262070 LEI · 529900PN7P0GSORO2174 TSXV Manufacturing
Open in API
Filings indexed 525 across all filing types
Latest filing 2021-06-28 Regulatory Filings
Country CA Canada
Listing TSXV THRM

About Therma Bright Inc.

https://www.thermabright.com/

Therma Bright Inc. is a medical technology company that develops, acquires, and markets proprietary diagnostic and medical device technologies for the consumer and institutional healthcare sectors. The company's portfolio addresses key areas including pain management, circulation, diagnostics, and critical care. Core products and development projects include Venowave, a medical device designed to boost circulation and prevent blood clots; the Digital Cough Test (DCT), an AI-powered application developed with AI4LYF for rapid, non-invasive detection of respiratory diseases; and the PREVA™ clot retriever, developed with Inretio for enhanced thrombectomy procedures in ischemic stroke treatment. Furthermore, Therma Bright is advancing inhaled statin therapy in partnership with InVixa for the treatment of COVID-19 pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-06-28 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing Therma Bright Inc.'s plans to test its AcuVid COVID-19 Rapid Antigen Saliva Test on the Delta variant of the virus and reporting the completion of a Brazilian clinical study for FDA Emergency Use Authorization submission. It contains no financial data, no regulatory filings, no management or board changes, no voting results, no earnings or annual report content. It is a corporate announcement about product development and clinical study progress. The document length is 5565 characters, which is relatively short and typical for a press release. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement or corporate news release that does not fit other specific categories.
2021-06-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Therma Bright Inc. reporting on the performance of its AcuVid COVID-19 Rapid Antigen Saliva Test from a Brazilian clinical study. It provides detailed clinical study results, mentions ongoing data collection, and discusses regulatory submission plans for FDA EUA and other health authorities. The document is a company announcement about clinical study progress and product performance, not a formal financial or regulatory filing. It does not contain financial statements, audit information, or detailed management discussion of financial results. It is also not a report publication announcement or certification. The content is primarily an update on clinical study results and regulatory plans, typical of a general regulatory announcement or company news release. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous company announcements that do not fit other specific categories.
2021-06-17 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2021-06-08 English
Material change report - English.PDF
Regulatory Filings
2021-05-27 English
News release - English.pdf
Regulatory Filings
2021-05-27 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.